Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2025

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity

A summary of option activity under the Equity Plans for the six months ended June 30, 2025 is as follows:

	Outstanding Awards
	Number of Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2024		1,144,690	$	0.81		9.23	$	20,160
Options granted		843,943		7.31
Outstanding as of June 30, 2025		1,988,633	$	3.57		9.17	$	2,128
Vested and expected to vest as of June 30, 2025		1,988,633	$	3.57		9.17	$	2,128
Exercisable as of June 30, 2025		497,265	$	0.93		8.54	$	920

Summary of RSAs Activity

A summary of RSAs activity under the 2019 Plan for the six months ended June 30, 2025 is as follows:

	Restricted Stock Awards			Weighted Average Grant Date Fair Value
Unvested as of December 31, 2024		1,839		$	1.71
Vested		(848	)		1.71
Unvested as of June 30, 2025		991		$	1.71

Schedule of Stock-based Compensation Expense

Stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the three and six months ended June 30, 2025 and 2024 is as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Research and development expenses	$	213	$	143	$	307	$	150
General and administrative expenses		378		179		658		203
Total stock-based compensation expense	$	591	$	322	$	965	$	353